What's new

Covid vaccine: UK supply hit by India delivery delay

Quite a ballz up really.
ok dude? c'mon...now your just turning them on by mentioning "ballz"! I'm just happy you didn't mention "hairy ballz" otherwise they would've had an instantaneous rectal orgasm! :lol:
Pathetic response...just another troll on this forum


Yeah, you'd rather end up being broke right
1. takes a troll to know a troll, so don't whine like a little pork chop just cuz I'm a better troll than you are. go have some fantashtik tea, it'll do your butthurt some good, just ask abhi-the-none-done. :coffee:
2. we are sitting on millions of tons of gold in our mountains an just as much in oil. will take it out when we want to. so we aren't the ones who are broke, you are. ;)
 
Last edited:
:rofl::rofl::rofl:

Yes you're a proper Wakanda aren't you ....Only poor from the outside
you can't deny those facts. not utilizing those gifts of nature is another discussion, we shall utilize when we want to. anyways, don't worry about us, worry about this...
000_1Q900W-ED-1024x683.jpg
 
Knew it, the Made in India vaccines are in Europe.

They are making the Astra-Zeneca vaccine.

Shame they made the mistake of with holding deliveries to the UK, that now means they wont get updates into the vaccine in the future as new variants are tackled. They failed to meet their part of the bargin to the UK..

Anyhow, the UK is moving to wards full turn key manufacturing in the UK, with a view that this becomes an export product. New facility will be online in 6months in Oxford..
 
They are making the Astra-Zeneca vaccine.

Shame they made the mistake of with holding deliveries to the UK, that now means they wont get updates into the vaccine in the future as new variants are tackled. They failed to meet their part of the bargin to the UK..

Anyhow, the UK is moving to wards full turn key manufacturing in the UK, with a view that this becomes an export product. New facility will be online in 6months in Oxford..

6 months lol... Hardly gonna make a difference by that time, UK is already reached 30 million people vaccinated or close to half their population, And will get most done by end of summer.

As far as exporting for the world goes then China and India will each produce a ~ Billion vaccines in the next 6 months, More if capacity is increased. Not to mention the American J&J vaccine also starting mass production and Sputnik V signing a deal with Indian pharma companies

There's not gonna be much left by the time British gets production ramped up
 
6 months lol... Hardly gonna make a difference by that time, UK is already reached 30 million people vaccinated or close to half their population, And will get most done by end of summer.

As far as exporting for the world goes then China and India will each produce a ~ Billion vaccines in the next 6 months, More if capacity is increased. Not to mention the American J&J vaccine also starting mass production and Sputnik V signing a deal with Indian pharma companies

There's not gonna be much left by the time British gets production ramped up

A flawed piece of logic. India has large manufacturing but low R&D capabilities, most of what it produces is under license.

The UK is looking to reduce the amount of license's it gives to India and make more medical products at home. Unless India can up her R&D, some of those factories will start to become idle and most countries move to making their medicines at home.

There is fallout from Covid, and alot of that is centred around supply line security for western countries and there will be changes ... watch this space ..
 
5 million doses are being delayed from India when around 40 million have already been given in the UK to 95% of the population groups that are likely to die.

UK still has supplies from its 2 factories in the UK for AstraZeneca vaccine and Pfizer is supplying from Belgium plant.

I agree with India that they need these supplies more than the UK as they have had a recent uptick in infections and since there was no specific guarantee about the exact date of this delivery, then India has not broken it's word.

Non-story and will barely make a ripple to the UK vaccine effort.


PS - More than 500,000 doses of vaccine had been given to UK citizens yesterday and there is plenty of supply to keep on vaccinating till the end of the month. There will be a slight dip at the start of April but this will then pick up as the first of the 15 million of the Moderna doses come on stream.
 
A flawed piece of logic. India has large manufacturing but low R&D capabilities, most of what it produces is under license.

The UK is looking to reduce the amount of license's it gives to India and make more medical products at home. Unless India can up her R&D, some of those factories will start to become idle and most countries move to making their medicines at home.

There is fallout from Covid, and alot of that is centred around supply line security for western countries and there will be changes ... watch this space ..

Lol keep up with the times , India is the world's largest vaccine producer and a lot of it is via indigenous pharma companies like Sun Pharma (3rd biggest in the world by production) and Cipla etc , There's a ton of domestic R&D involved and they make most of their profits with US,UK sales .and there is massive untapped growth potential both domestically and in SE Asia etc .

If the "west" decides to pull back its manufacturing to home to their own countries their production prices will rocket , profit margins will shrink and drug prices will rise and they'll find it harder to compete with Indian,Chinese brands . So I doubt the likes of GSK,Novartis etc would simply go along with that decision

As far as covid vaccine goes then there too we're not waiting hand on foot for AstraZeneca's IP . We have one homemade already in mass production (Covaxin by Bharat Biotech ) which will hit 700 million doses by end of year .

Then there's the other vaccines currently under trial and development here

  • ZyCov-Di, being developed by Ahmedabad-based Zydus-Cadila
  • A vaccine being developed by Hyderabad-based Biological E, the first Indian private vaccine-making company, in collaboration with US-based Dynavax and Baylor College of Medicine
  • HGCO19, India's first mRNA vaccine made by Pune-based Genova in collaboration with Seattle-based HDT Biotech Corporation, using bits of genetic code to cause an immune response
  • A nasal vaccine by Bharat BioTech
  • The Sputnik V vaccine candidate developed by Dr Reddy's Lab and Gamaleya National Centre in Russia
  • A second vaccine being developed by Serum Institute of India and American vaccine development company Novavax


So no , We're not dependent on any one company or country , If AstraZeneca or Bojo decides he wants to take 6 months setting up a factory in the UK then be our guest ....We have plenty of other things going on .


This is nothing new , When the American and European brands were charging 10,,000-15,000 $ per shot for the HIV cocktail at the height of the African AIDS epidemic in the 1990's it was Cipla who stepped up ,came up with their own cocktail and sold it to poor countries and Doctors without Borders for as little as 300$
 
A flawed piece of logic. India has large manufacturing but low R&D capabilities, most of what it produces is under license.

The UK is looking to reduce the amount of license's it gives to India and make more medical products at home. Unless India can up her R&D, some of those factories will start to become idle and most countries move to making their medicines at home.

There is fallout from Covid, and alot of that is centred around supply line security for western countries and there will be changes ... watch this space ..
Boris Johnson should talk to his ally Biden who just agreed aiding India in ramping up vaccine production capacities. We will move to J&J and Covaxin if AZ is not viable then.
 
They are making the Astra-Zeneca vaccine.

Shame they made the mistake of with holding deliveries to the UK, that now means they wont get updates into the vaccine in the future as new variants are tackled. They failed to meet their part of the bargin to the UK..

Anyhow, the UK is moving to wards full turn key manufacturing in the UK, with a view that this becomes an export product. New facility will be online in 6months in Oxford..
India did give out vaccines to other countries instead of UK so that make sense
A flawed piece of logic. India has large manufacturing but low R&D capabilities, most of what it produces is under license.

The UK is looking to reduce the amount of license's it gives to India and make more medical products at home. Unless India can up her R&D, some of those factories will start to become idle and most countries move to making their medicines at home.

There is fallout from Covid, and alot of that is centred around supply line security for western countries and there will be changes ... watch this space ..
Make more sense to make it at home since UK is no longer in the EU.
 
Lol keep up with the times , India is the world's largest vaccine producer and a lot of it is via indigenous pharma companies like Sun Pharma (3rd biggest in the world by production) and Cipla etc , There's a ton of domestic R&D involved and they make most of their profits with US,UK sales .and there is massive untapped growth potential both domestically and in SE Asia etc .

If the "west" decides to pull back its manufacturing to home to their own countries their production prices will rocket , profit margins will shrink and drug prices will rise and they'll find it harder to compete with Indian,Chinese brands . So I doubt the likes of GSK,Novartis etc would simply go along with that decision

As far as covid vaccine goes then there too we're not waiting hand on foot for AstraZeneca's IP . We have one homemade already in mass production (Covaxin by Bharat Biotech ) which will hit 700 million doses by end of year .

Then there's the other vaccines currently under trial and development here

  • ZyCov-Di, being developed by Ahmedabad-based Zydus-Cadila
  • A vaccine being developed by Hyderabad-based Biological E, the first Indian private vaccine-making company, in collaboration with US-based Dynavax and Baylor College of Medicine
  • HGCO19, India's first mRNA vaccine made by Pune-based Genova in collaboration with Seattle-based HDT Biotech Corporation, using bits of genetic code to cause an immune response
  • A nasal vaccine by Bharat BioTech
  • The Sputnik V vaccine candidate developed by Dr Reddy's Lab and Gamaleya National Centre in Russia
  • A second vaccine being developed by Serum Institute of India and American vaccine development company Novavax


So no , We're not dependent on any one company or country , If AstraZeneca or Bojo decides he wants to take 6 months setting up a factory in the UK then be our guest ....We have plenty of other things going on .


This is nothing new , When the American and European brands were charging 10,,000-15,000 $ per shot for the HIV cocktail at the height of the African AIDS epidemic in the 1990's it was Cipla who stepped up ,came up with their own cocktail and sold it to poor countries and Doctors without Borders for as little as 300$
Yes shaar! Keeping up with the times is berry important.


Lot's of naysayers here said the supply line is in trouble. Upramping of products will never occur in India. No problem I told them. It's not like the glorified corner-shop chit stamping mentality at SII can't cope with real contracts and real capitalism. I assured the doubters that the executive board at SII made up of kaka and chachee and mum-in-law and her bestie will come through when actually tested. Indian biotech is phully capable shaar of competing with the best shaar jee.

Great work by world's greatest pharmacy. "We Brits" are proud of "our" global overseas partners. Who needs Europe with their checks, balances and safeguards eh?
 

"In a private briefing to MPs last week, he said that by next year Britain will have the capacity to make 140 million vaccine doses a year at a new site in Oxford, a further 140 million in Braintree, Essex, and 200 million a year in Livingston in Scotland."

UK will be come a competitor to SI as it has far greater R&D capabilities in this space, which should translate into new products and exports from the UK and also the with-holding of licenses to SI to make vaccines for new variants. Modi's mistake to with-hold vaccines to the UK and has proven and reinforced the need to bring back manufacturing for vaccines from India, back to the UK.
 

Back
Top Bottom